ECTRIMS 2022 Stem Cell Transplant Trumps Fingolimod for RRMS Relapse Risk Autologous hematopoietic stem cell transplantation is linked to significantly lower relapse rates than fingolimod in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback